| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 2.939 | 9.696 | 1.773 | 395 | 0 | 827 | 3.069 | 1.229 | 4.454 | 0 |
| Total Income - EUR | 2.939 | 9.745 | 1.872 | 395 | 0 | 827 | 3.079 | 1.229 | 4.454 | 0 |
| Total Expenses - EUR | 2.271 | 8.502 | 3.287 | 637 | 266 | 146 | 2.234 | 398 | 544 | 118 |
| Gross Profit/Loss - EUR | 669 | 1.243 | -1.415 | -242 | -266 | 681 | 845 | 831 | 3.909 | -118 |
| Net Profit/Loss - EUR | 580 | 951 | -1.471 | -254 | -266 | 656 | 755 | 794 | 3.349 | -118 |
| Employees | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Joy Pharma Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 2.582 | 8.108 | 6.721 | 6.597 | 6.470 | 6.347 | 6.206 | 6.226 | 6.207 | 6.172 |
| Current Assets | 2.894 | 4.514 | 830 | 718 | 305 | 374 | 8.506 | 9.456 | 12.860 | 12.548 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 5.586 | 5.480 | 5.464 | 5.434 |
| Receivables | 0 | 327 | 56 | 55 | 77 | 0 | 1.061 | 1.064 | 1.061 | 1.055 |
| Cash | 2.894 | 4.188 | 774 | 663 | 228 | 374 | 1.858 | 2.911 | 6.335 | 6.060 |
| Shareholders Funds | 625 | 1.570 | 72 | -183 | -420 | 244 | 994 | 1.791 | 5.135 | 4.988 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 4.850 | 11.053 | 7.479 | 7.499 | 7.195 | 6.477 | 13.719 | 13.891 | 13.932 | 13.732 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4619 - 4619" | |||||||||
| CAEN Financial Year |
4619
|
|||||||||
Comments - Joy Pharma Srl